OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
Per the agreement terms, select assets of BioReference Health, a wholly-owned subsidiary of OPKO Health, will be acquired by Labcorp. The transaction, expected to close in the second half of 2024, is subject to customary closing conditions and applicable regulatory approvals. The assets that will be acquired from OPKO Health currently generate approximately $100 million in annual revenues. The latest announcement is expected to enable OPKO Health to strengthen its foothold in the biopharmaceutical space. Rationale Behind the Agreement Through the transaction, OPKO Health's BioReference Health's laboratory testing businesses focused on clinical diagnostics and reproductive and women's health across the United States outside of New York and New Jersey will be acquired by Labcorp. The transaction includes patient service centers and certain customer contracts and operating assets. However, BioReference Health will continue to offer oncology and urology diagnostic services nat
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- GeneDx Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]Yahoo! Finance
- GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset [Yahoo! Finance]Yahoo! Finance
- GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 [Yahoo! Finance]Yahoo! Finance
- OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.MarketBeat
- OPKO Health, Inc. (NASDAQ: OPK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $1.50 price target on the stock.MarketBeat
OPK
Earnings
- 2/27/24 - In-Line
OPK
Sec Filings
- 3/29/24 - Form 4
- 3/29/24 - Form 4
- 3/29/24 - Form 4
- OPK's page on the SEC website